BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 20924158)

  • 1. Pediatric Graves' disease: controversies in management.
    Rivkees SA
    Horm Res Paediatr; 2010; 74(5):305-11. PubMed ID: 20924158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithyroid drug treatment for graves' disease in children: a long-term retrospective study at a single institution.
    Ohye H; Minagawa A; Noh JY; Mukasa K; Kunii Y; Watanabe N; Matsumoto M; Suzuki M; Yoshihara A; Ito K; Ito K
    Thyroid; 2014 Feb; 24(2):200-7. PubMed ID: 23926918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithyroid drugs in the management of patients with Graves' disease: an evidence-based approach to therapeutic controversies.
    Cooper DS
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3474-81. PubMed ID: 12915620
    [No Abstract]   [Full Text] [Related]  

  • 4. Definitive treatment of Graves' disease in children and adolescents.
    Król A; Czarniecka A; Jarząb B
    Endokrynol Pol; 2021; 72(6):661-665. PubMed ID: 34855196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
    Ward L; Huot C; Lambert R; Deal C; Collu R; Van Vliet G
    Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Antithyroid Drug Treatment of Graves' Disease in Children and Adolescents: A 20-Year Single-Center Experience.
    Song A; Kim SJ; Kim MS; Kim J; Kim I; Bae GY; Seo E; Cho YS; Choi JY; Cho SY; Jin DK
    Front Endocrinol (Lausanne); 2021; 12():687834. PubMed ID: 34194397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease.
    Hancock LD; Tuttle RM; LeMar H; Bauman J; Patience T
    Clin Endocrinol (Oxf); 1997 Oct; 47(4):425-30. PubMed ID: 9404440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease.
    Alexander EK; Larsen PR
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1073-7. PubMed ID: 11889166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment outcome of Graves' disease in Thai children.
    Somnuke PH; Pusuwan P; Likitmaskul S; Santiprabhob J; Sawathiparnich P
    J Med Assoc Thai; 2007 Sep; 90(9):1815-20. PubMed ID: 17957924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controversies in the management of Graves' disease in children.
    Rivkees SA
    J Endocrinol Invest; 2016 Nov; 39(11):1247-1257. PubMed ID: 27153850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Long-Term Outcome of Treatment for Graves' Hyperthyroidism.
    Sjölin G; Holmberg M; Törring O; Byström K; Khamisi S; de Laval D; Abraham-Nordling M; Calissendorff J; Lantz M; Hallengren B; Filipsson Nyström H; Wallin G
    Thyroid; 2019 Nov; 29(11):1545-1557. PubMed ID: 31482765
    [No Abstract]   [Full Text] [Related]  

  • 12. "Block-and-replace" treatment in Graves' disease: experience in a cohort of pediatric patients.
    Vigone MC; Peroni E; Di Frenna M; Mora S; Barera G; Weber G
    J Endocrinol Invest; 2020 May; 43(5):595-600. PubMed ID: 31713721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approach to the Patient: Management and the Long-term Consequences of Graves' Disease in Children.
    Rivkees SA
    J Clin Endocrinol Metab; 2022 Nov; 107(12):3408-3417. PubMed ID: 36184734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controversies in the pharmacological treatment of Graves' disease in children.
    De Luca F; Valenzise M
    Expert Rev Clin Pharmacol; 2018 Nov; 11(11):1113-1121. PubMed ID: 30417713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approach to the pediatric patient with Graves' disease: when is definitive therapy warranted?
    Bauer AJ
    J Clin Endocrinol Metab; 2011 Mar; 96(3):580-8. PubMed ID: 21378220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tale of radioiodine and Graves' orbitopathy.
    Ponto KA; Zang S; Kahaly GJ
    Thyroid; 2010 Jul; 20(7):785-93. PubMed ID: 20578895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does thyroidectomy, radioactive iodine therapy, or antithyroid drug treatment alter reactivity of patients' T cells to epitopes of thyrotropin receptor in autoimmune thyroid diseases?
    Soliman M; Kaplan E; Abdel-Latif A; Scherberg N; DeGroot LJ
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2312-21. PubMed ID: 7543112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effectiveness of therapies for Graves' hyperthyroidism: a systematic review and network meta-analysis.
    Sundaresh V; Brito JP; Wang Z; Prokop LJ; Stan MN; Murad MH; Bahn RS
    J Clin Endocrinol Metab; 2013 Sep; 98(9):3671-7. PubMed ID: 23824415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and treatment of Graves disease.
    Streetman DD; Khanderia U
    Ann Pharmacother; 2003; 37(7-8):1100-9. PubMed ID: 12841824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation and Management of Children with Thyrotoxicosis.
    Leung AKC; Leung AAC
    Recent Pat Endocr Metab Immune Drug Discov; 2017; 11(1):22-31. PubMed ID: 29589552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.